MI Tech, a global fire extinguisher stent company, announced that its annual sales on a consolidated..

*A panoramic view of the headquarters of MI Tech in Pyeongtaek, Gyeonggi-do. [MITECH]*

MI Tech, a global fire extinguisher stent company, announced that its annual sales on a consolidated basis in 2025 were 67.2 billion won, up 25.1% from the previous year.

Operating profit was KRW 20.7 billion and net profit was KRW 20.4 billion, up 17.8% and 11.3%, respectively, from the previous year. Both sales and operating profit reached new highs at the same time since its foundation in 1991.

This good performance is interpreted as a result of the reorganization of global partnerships and the effects of new products. It maintained a firm No. 1 position in the Japanese non-vascular stent market, which accounts for a large portion of total sales.

In particular, strong sales of the new “Multi-hole” stent drove external growth and contributed greatly to the overall sales expansion.

In the European market, the strategy to streamline local sales networks was effective. We have re-established optimized distribution partnerships for each major counattempt and achieved qualitative growth through profitability-oriented supply contracts.

In the North American market, sales grew about 35% year-on-year as a result of strengthening local marketing even when sales items were limited. The domestic sales division also supported its solid performance.

Demand for products from major domestic medical institutions has been on track, driving sales recovery. In 2025, the operating margin recorded 30.8%, maintaining a solid high-yield structure of 30%.

“2025 was a year that expanded its influence in the main markets of Europe and Japan and strengthened profitability-oriented internal management,” declared Kwak Jae-oh, CEO of MI Tech. “In 2026, we expect external growth in North America, Europe and Asia, in addition to our firm market dominance in Japan.”